[Retracted] Fetal Congenital Cardiac and Vascular Disorders Associated with Sertraline Treatment during Pregnancy: Analysis of FAERS Data

Table 2

Characteristics of reports associated with sertraline.

	Reports no.	%
Reporting region
Europe	145	15.86%
Oceania	2	0.22%
Americas	729	79.76%
Asia	37	4.05%
Africa	1	0.11%
Reported year
2004 and before	224	24.42%
2005	47	5.15%
2006	58	6.35%
2007	58	6.35%
2008	60	6.57%
2009	55	6.02%
2010	78	8.54%
2011	68	7.45%
2012	44	4.82%
2013	11	1.2%
2014	35	3.83%
2015	33	3.61%
2016	49	5.37%
2017	25	2.74%
2018	10	1.1%
2019	31	3.4%
2020	20	2.19%
2021Q1Q2	8	0.88%
Gender
Female	386	42.23%
Male	393	43%
Unknown	135	14.77%
Outcome
Congenital anomaly	774	41.21%
Death	67	3.57%
Disability	21	1.12%
Hospitalization—initial or prolonged	220	11.71%
Life-threatening	124	6.6%
Other serious (important medical event)	664	35.36%
Required intervention to prevent permanent impairment/damage	8	0.43%